Ask AI
ProCE Banner Activity

Do It Better: Effective Strategies for Implementing Evidence-Based, Patient-Centered Care in Cardio-Renal-Metabolic Disease

Slideset

Expert-curated slides on the importance of identifying cardio-renal-metabolic disease early and integrating SGLT2 inhibitors to lower A1C levels, provide renal protection, and/or include greater weight loss in patients with type 2 diabetes and comorbid chronic kidney disease, overweight, and/or obesity.

Released: October 03, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company